The Pharmaceutical Studies Reader

Title Page
Copyright Page
Contents
Acknowledgements
Chapter 1 Introduction
	Why Study Pharmaceuticals?
	A Prehistory of Pharmaceutical Studies
	Key Themes in Pharmaceutical Studies
	Guide to this Volume
	Notes
Part I Pharmaceutical Lives
	Chapter 2 The Pharmaceuticalisation of Society? A Framework for Analysis
		Introduction
		Definition, Delineation and Dynamics: What is Pharmaceuticalisation?
		Trends and Transformations
		Discussion
		References
	Chapter 3 Pharmaceutical Witnessing: Drugs for Life in an Era of Direct-to-Consumer Advertising
		Remaking the Body at Risk
		Awareness Through Education
		Personalizing the Risk
		Motivation to Informing Self-diagnosis
		Convincing the Doctor, the Critical Moment
		Branded Compliance
		Conclusion
		Note
		References
Part II New Drugs, Diseases, and Identities
	Chapter 4 Releasing the Flood Waters: Diuril and the Reshaping of Hypertension
		Introduction
		Diuril in the Life of the Pharmaceutical Firm
		Attachment: Diuril Meets Hypertension
		Clinical Research as a Marketing Arena
		Public Relations and Popular Media
		“Ethical Marketing”: The Detail Man and the Diuril Man
		Reception: Diuril and Hypertension in Practice
		Expanding the Ranks of the Treatable
		Detaching “Diuril” from Hypertension
		Notes
	Chapter 5 Dep®ession and Consum♀tion: Psychopharmaceuticals, Branding, and New Identity Practices
		Introduction
		Branded Identity and “Symbolic Mistakes”: The New Social Lives of Pharmaceuticals
		Markets, Molecules and Meanings
		Sarafeminism?
		Premenstrual Dysphoric Disorder in the Making
		Symbolic Side Effects
		Marketing (and) Medical Turf: Symbolic Fallout
		Conclusions
		Notes
		References
	Chapter 6 BiDil: Medicating the Intersection of Race and Heart Failure
		Considering Heart Failure as a Disease Category
		BiDil’s Contingent History: V-HeIT to A-HeIT
		Too High a Price?
		Pharmakon
		The Material-semiotic
		Conclusion
		Notes
		Works Cited
	Chapter 7 Manufacturing Desire: The Commodification of Female Sexual Dysfunction
		New Diagnoses for New Drugs: Creating a Market
		The Commodification of Continuing Medical Education
		The Celebrity of the ‘Sex Expert’: Media and the Commodification of Female Sexual Dysfunction
		Robust Pipelines
		Notes
		References
Part III Drugs and the Circulation of Medical Knowledge
	Chapter 8 Following the Script: How Drug Reps Make Friends and Influence Doctors
		Better than You Know Yourself
		Script Tracking
		The Value of Samples
		Funding Friendship
		Conclusion
		References
	Chapter 9 Getting to Yes: Corporate Power and the Creation of a Psychopharmaceutical Blockbuster
		From Schizophrenia to Complicated Moods: The Evolution of Zyprexa
		Marketing Channels and Synergistic Power: Conclusion
		Notes
		References
	Chapter 10 Pushing Knowledge in the Drug Industry: Ghost-Managed Science
		Introduction
		A Sample Manuscript
		Publication Planning 101/201: An Insider View of the Field
		Marketing
		Medical Journals
		Authorship and its Limits
		Creating Knowledge Through Mediation
		Changing Trajectories?
		Discussion
		Notes
		References
	Chapter 11 Transcultural Medicine: A Multi-Sited Ethnography on the Scientific-Industrial Networking of Korean Medicine
		A Brief Modern History of Korean Medicine and its Transformation
		KM Doctors’ Global Experiences: Biographical Accounts
		Hybrid and Modernized Practice: The Production of Hybrid KM Treatments in the KM Clinic
		Laboratory Practice and the Scientization of Herbal Therapies
		Network of Networks: Industrialization Process of Herbal Medicine in the Purimed Company
		Transcultural Medicine and Emergence of New Medical Assemblage in Global Power Relations
		Conclusion
		Notes
		References
Part IV Political and Moral Economies of Pharmaceutical Research
	Chapter 12 Uncommon Trajectories: Steroid Hormones, Mexican Peasants, and the Search for a Wild Yam
		Introduction
		Hormones in the Laboratory
		In Search of a Wild Yam
		The Birth of Syntex
		George Rosenkranz and the Study of Chemistry in Mexico
		Human Faces Beyond the Laboratories: Mexicans Search for Barbasco
		Carl Djerassi: Syntex, Cortisone, and an Amazing Mexican Yam
		Conclusion
		Notes
		References
	Chapter 13 “Ready-to-Recruit” or “Ready-to-Consent” Populations?: Informed Consent and the Limits of Subject Autonomy
		Recruitment and Informed Consent
		Analysis of Advertisements
		Participation and Informed Consent
		Conclusion
		Notes
		References
	Chapter 14 Clinical Trials Offshored: On Private Sector Science and Public Health
		Clinical Trial Environments
		Pharmaceutical Capital: Contract Research in Brief
		Constructing Global Subjects
		Keeping the Clinical Trial Market in Poland
		‘Pharmaceuticals are the New Gold’
		Notes
		References
	Chapter 15 The Experimental Machinery of Global Clinical Trials: Case Studies from India
		The Indian Clinical Trials Landscape
		A Critique of the Global Biomedical Economy: Expropriation, Exploitation, and the Structural Violence of Biocapital
		Notes
Part V Intellectual Property in Local and Global Markets
	Chapter 16 Intellectual Property and Public Health: Copying of HIV/AIDS Drugs by Brazilian Public and Private Pharmaceutical Laboratories
		Introduction
		Public Health Policy and Local Production of Generic Drugs
		The Unpatentable Status of Drugs in Brazil from 1945 to 1996: A Licit Copying Regime
		Copying and Technological Learning
		Copying and Pharmaceutical Innovations
		Conflict Between the Brazilian Health Ministry and International Laboratories: Negotiations on Prices and Compulsory Licences
		Conclusions
		Notes
	Chapter 17 Global Pharmaceutical Markets and Corporate Citizenship: The Case of Novartis’ Anti-Cancer Drug Glivec
		Novartis versus the Government of India
		Pharmaceutical Citizens versus Novartis
		Pharmaceutical Citizens Pro Novartis
		Give to the Poor to Take from the Rich
		Note
		References
	Chapter 18 Generic Medicines and the Question of the Similar
		A New Market?
		The Similar and the “Similar”
		Generics and the Social Studies of Science and Technology
		Notes
		References
Index
EULA